Title: Pexelizumab, a C5 complement inhibitor, reduces 30-day mortality in patients undergoing coronary artery bypass surgery or receiving reperfusion therapy for acute myocardial infarction
Authors: Van de Werf, Frans
Armstrong, PW
Levy, J
Granger, CB
Califf, RM
Adams, PX
VanderLaan, M
Mojcik, C
Todaro, TG
Verrier, ED
Issue Date: 2004
Publisher: Elsevier Biomedical
Host Document: Journal of the American College of Cardiology vol:43 issue:5 pages:474A-474A
Conference: 54th Annual Scientific Session of the American-College-of-Cardiology location:New Orleans date:07-10 March 2004
ISSN: 0735-1097
Publication status: published
KU Leuven publication type: IMa
Appears in Collections:Cardiology

Files in This Item:

There are no files associated with this item.


All items in Lirias are protected by copyright, with all rights reserved.